Skip to main
AKTX
AKTX logo

Akari Therapeutics (AKTX) Stock Forecast & Price Target

Akari Therapeutics (AKTX) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 80%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 20%
Akari Therapeutics (AKTX) has been analyzed by 5 analysts, with a consensus rating of Buy. 80% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 20% predict a Strong Sell.

This aggregate rating is based on analysts' research of Akari Therapeutics and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Akari Therapeutics (AKTX) Forecast

Analysts have given Akari Therapeutics (AKTX) a Buy based on their latest research and market trends.

According to 5 analysts, Akari Therapeutics (AKTX) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Akari Therapeutics (AKTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.